CR: Developing an Intervention to Improve Acceptance of Referral in HF (NCT04276675) | Clinical Trial Compass
CompletedNot Applicable
CR: Developing an Intervention to Improve Acceptance of Referral in HF
United Kingdom68 participantsStarted 2020-02-05
Plain-language summary
Background: There are proven benefits to people with chronic heart failure (CHF) participating in a cardiac rehabilitation (CR) programme, however uptake remains disappointingly low. Admission to hospital presents a significant opportunity to offer CR referral to such a patient population. It is believed that up to 75% of patients with CHF show signs of frailty at discharge which might impact on the rate of patients' acceptance of referral to CR.
Aim: To explore the impact of frailty on patient acceptance of referral to CR following admission to hospital with an episode of decompensated CHF.
Methods and expected outcome: We will conduct an observational study assessing the relationship between frailty and acceptance of referral to CR in this patient population. It will also explore what factors impact that relationship including demographic factors, measures of self-care and patient activation measure (PAM).
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Observational study:
Inclusion Criteria:
* Clinical diagnosis of chronic heart failure confirmed by cardiac imaging.
* Current admission for which the primary reason was decompensated heart failure requiring IV diuretics
* Referred to the acute trusts heart failure nursing service
* Able to give informed consent
* Able to communicate in spoken English
Exclusion Criteria:
* Contraindications to participating in cardiac rehabilitation as detailed in ESC consensus statement e.g. uncontrolled hypertension severe aortic stenosis, unstable angina
* Moderate to severe cognitive impairment
* Patients with severe dependence prior to index admission (inability to carry out ADL)
* Admitted from a nursing home
* Resident 'out of area'
* Significant co-morbidities that would limit participation in a cardiac rehabilitation programme e.g. neurodegenerative conditions
* Previous recruitment onto this study
Semi-structured interviews: Purposive sampling
Inclusion criteria:
* Patients with chronic heart failure who fulfil the criteria for referral to the cardiac rehabilitation service will be eligible to participate in the interviews if they are:
* Age 18 years or over
* Have a clinical diagnosis of CHF confirmed by cardiac imaging.
* Referred to the acute trusts heart failure nursing service and/or cardiac rehabilitation team
* Able to give informed consent
* Able to communicate in spoken English
Exclusion criteria:
* Contraindications to participating in cardiac rehabilitation as de…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Acceptance of referral to cardiac rehabilitation
Timeframe: Within 7 days from baseline visit
2
Qualitative evaluation of impact of offer of referral to cardiac rehabilitation service